|
Variable
|
GMR±
|
95% CI*
|
Adjusted GMR±
|
95% CI*
|
P
|
|---|
|
Sex
| | | | | |
|
Men
|
1
| |
1
| |
0.007
|
|
Women
|
1.13
|
1.06-1.21
|
1.12
|
1.03-1.22
| |
|
Age group
| | | | | |
|
0-5 years
|
0.87
|
0.75-0.99
|
1.02
|
0.84-1.24
|
0.526
|
|
5-15 years
|
1.16
|
0.99-1.37
|
1.14
|
0.93-1.39
| |
|
15-25 years
|
1.00
|
0.89-1.23
|
0.93
|
0.81-1.08
| |
|
25-35 years
|
1
| |
1
| | |
|
35-45 years
|
1.00
|
0.92-1.08
|
0.96
|
0.87-1.06
| |
|
≥ 45 years
|
1.00
|
0.90-1.10
|
0.96
|
0.84-1.09
| |
|
Site of HIV test
| | | | | |
|
QECH
|
1
| |
1
| | |
|
Facility other than QECH
|
1.65
|
1.54-1.77
|
1.61
|
1.47-1.77
|
<0.001
|
|
Unknown
|
1.82
|
1.64-2.02
|
1.93
|
1.66-2.24
| |
|
WHO stage at registration
| | | | | |
|
Stage 1 or 2
|
1
| | | | |
|
Stage 3 or 4
|
1.01
|
0.95-1.08
| | | |
|
CD4 count (cells/μl)
| | | | | |
|
≥ 350
|
1
| |
1
| |
<0.001
|
|
250 – 350
|
0.87
|
0.70-1.11
|
0.96
|
0.75-1.20
| |
|
50 – 250
|
0.76
|
0.61-0.95
|
0.77
|
0.62-0.98
| |
|
<50
|
0.50
|
0.40-0.63
|
0.53
|
0.42-0.68
| |
|
Year of ART initiation
| | | | | |
|
2004
|
0.92
|
0.75-1.14
|
0.79
|
0.52-1.21
|
0.004
|
|
2005
|
1
| |
1
| | |
|
2006
|
0.72
|
0.60-0.87
|
0.75
|
0.48-1.16
| |
|
2007
|
0.64
|
0.55-0.76
|
0.71
|
0.50-1.03
| |
|
2008
|
0.68
|
0.59-0.80
|
0.72
|
0.51-1.02
| |
|
2009
|
0.69
|
0.59-0.80
|
0.69
|
0.49-0.99
| |
|
2010
|
0.75
|
0.64-0.88
|
0.85
|
0.60-1.21
| |
|
2011
|
0.54
|
0.47-0.63
|
0.84
|
0.59-1.21
| |
|
Number of ART initiators per year (continuous)
|
1.00
|
1.00-1.00
| | | |
-
±Bootstrapped estimates of geometric mean ratios, adjusted for sex, age group, site of HIV test, CD4 count strata and year of ART initiation.
-
*Bias corrected accelerated 95% confidence intervals.
-
GMR Geometric mean ratio, CI confidence interval, QECH Queen Elizabeth Central Hospital.
